Cost of senile cataract surgery in 65 population in the Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F44555601%3A13510%2F17%3A43895268" target="_blank" >RIV/44555601:13510/17:43895268 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/68407700:21460/17:00317610

Výsledek na webu

<a href="http://cefe.ekf.tuke.sk/CEFE2017_final.pdf" target="_blank" >http://cefe.ekf.tuke.sk/CEFE2017_final.pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Cost of senile cataract surgery in 65 population in the Czech Republic

Popis výsledku v původním jazyce

The objective of this study is to quantify direct costs related to different types of implanted intraocular lenses from the perspective of public health insurance and from the patient&apos;s perspective. The calculations were carried out based on three scenarios. The first scenario describes the real current situation, when the health insurance company reimburses the performances related to the senile cataract treatment including a monofocal artificial intraocular lens (IOL), and the patient pays for all the materials in the case he/she requires a multifocal or toric IOL. The second scenario analyses the situation, when there was the category of so-called &quot;nadstandard&quot; (better care than the standard one) in the Czech healthcare system. In this case, the health insurance company reimburses the performances related to the senile cataract treatment including the sum equivalent to the price of a monofocal IOL as the cheapest option. The patient pays the price difference between the implanted toric or multifocal lens and an equivalent monofocal lens. The third scenario describes the situation corresponding to the judicial interpretation of the Constitutional Court of the Czech Republic, when the health insurance company reimburses only the performances related to the senile cataract treatment including a monofocal IOL, and if a patient requires a multifocal or toric IOL, he/she pays for the whole operation including the materials himself/herself. The study covered a cohort of 200 patients with senile cataract in the age of 65 and over. Data were collected from four cataract surgery performing clinics in 2014. Patients&apos; costs were obtained through a patient questionnaire asking the direct (out-of-pocket) expenses associated with the cataract surgery. Direct costs of the senile cataract surgery from the perspective of public health insurance were CZK 24,900 (about EUR 907) per person (one eye). Patient&apos;s direct costs were lower for monofocal lenses than for multifocal ones. Patients&apos; costs for an IOL and the related treatment reached up to CZK 35,000 (about EUR 1,275), out of pocket expenses after the treatment averaged out at CZK 4,450 (about EUR 162). The most cost-effective option from the patients&apos; perspective is the monofocal IOL, however, the patients would spend a higher sum of money for the eyeglasses after the operation. Nevertheless, it is still less than the material costs in the case of a multifocal IOL, which, moreover, is not suitable for all patients. Thus, the monofocal IOL appears to be the best option from the point of view of cost effectiveness both from the perspective of public health insurance and from the patient&apos;s perspective.

Název v anglickém jazyce

Cost of senile cataract surgery in 65 population in the Czech Republic

Popis výsledku anglicky

The objective of this study is to quantify direct costs related to different types of implanted intraocular lenses from the perspective of public health insurance and from the patient&apos;s perspective. The calculations were carried out based on three scenarios. The first scenario describes the real current situation, when the health insurance company reimburses the performances related to the senile cataract treatment including a monofocal artificial intraocular lens (IOL), and the patient pays for all the materials in the case he/she requires a multifocal or toric IOL. The second scenario analyses the situation, when there was the category of so-called &quot;nadstandard&quot; (better care than the standard one) in the Czech healthcare system. In this case, the health insurance company reimburses the performances related to the senile cataract treatment including the sum equivalent to the price of a monofocal IOL as the cheapest option. The patient pays the price difference between the implanted toric or multifocal lens and an equivalent monofocal lens. The third scenario describes the situation corresponding to the judicial interpretation of the Constitutional Court of the Czech Republic, when the health insurance company reimburses only the performances related to the senile cataract treatment including a monofocal IOL, and if a patient requires a multifocal or toric IOL, he/she pays for the whole operation including the materials himself/herself. The study covered a cohort of 200 patients with senile cataract in the age of 65 and over. Data were collected from four cataract surgery performing clinics in 2014. Patients&apos; costs were obtained through a patient questionnaire asking the direct (out-of-pocket) expenses associated with the cataract surgery. Direct costs of the senile cataract surgery from the perspective of public health insurance were CZK 24,900 (about EUR 907) per person (one eye). Patient&apos;s direct costs were lower for monofocal lenses than for multifocal ones. Patients&apos; costs for an IOL and the related treatment reached up to CZK 35,000 (about EUR 1,275), out of pocket expenses after the treatment averaged out at CZK 4,450 (about EUR 162). The most cost-effective option from the patients&apos; perspective is the monofocal IOL, however, the patients would spend a higher sum of money for the eyeglasses after the operation. Nevertheless, it is still less than the material costs in the case of a multifocal IOL, which, moreover, is not suitable for all patients. Thus, the monofocal IOL appears to be the best option from the point of view of cost effectiveness both from the perspective of public health insurance and from the patient&apos;s perspective.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

50204 - Business and management

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

Central european conference in finance and economics (CEFE2017)

ISBN

978-80-553-2906-2

ISSN

—

e-ISSN

—

Počet stran výsledku

10

Strana od-do

70-79

Název nakladatele

Technická univerzita Košice

Místo vydání

Košice

Místo konání akce

Herlany

Datum konání akce

20. 9. 2017

Typ akce podle státní příslušnosti

EUR - Evropská akce

Kód UT WoS článku

000503056700007